Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Basophils are back!

Stephen J Galli1, Christopher B Franco

  • 1Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305-5324, USA. sgalli@stanford.edu

Immunity
|April 11, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct phosphoinositide signatures orchestrate FcεRI versus MRGPRX2 mast cell secretion.

iScience·2026
Same author

Identification of Shared Regulators of IgE- and MRGPRX2-Dependent Degranulation in Human Mast Cells.

Allergy·2026
Same author

Peanut allergy oral immunotherapy drives single-cell multi-omic changes in peanut-reactive T cells associated with sustained unresponsiveness.

Nature immunology·2025
Same author

Mouse and human mast cells can release prestored CSF1.

The Journal of allergy and clinical immunology·2025
Same author

Discovery and Mechanistic Insights into Vascular Permeability Factor/Vascular Endothelial Growth Factor through the Work of Harold F. Dvorak and Ann M. Dvorak.

The American journal of pathology·2025
Same author

Evolution of mast cell research associated with the Laboratory of Allergic Diseases, 1985-2022: Summary of the 2023 NIAID Symposium.

The Journal of allergy and clinical immunology·2025
Same journal

Targeting cholesterol esterification sensitizes liver cancer to CD8<sup>+</sup> T cell attack by impairing metabolic and redox resilience.

Immunity·2026
Same journal

Brain endothelial cells orchestrate a neuroprotective antiviral state in the CNS in response to peripheral viral pattern sensing.

Immunity·2026
Same journal

Extracellular ATP-P2RY2 signaling drives intratumoral prostaglandin E2 accumulation and adaptive resistance to immunotherapy in solid tumors.

Immunity·2026
Same journal

B cell-derived type I interferon sustains T cell functionality upon strong TCR stimulation during chronic infection.

Immunity·2026
Same journal

Lactate binds and inhibits the innate immune sensor STING to promote tumor immune evasion.

Immunity·2026
Same journal

Antibody binding geometry and affinity control inhibitory hFcγRIIB receptor signaling.

Immunity·2026
See all related articles

Platelet-activating factor release from basophils is crucial for IgG1-antigen immune complex-induced anaphylaxis in mice. This study reveals a novel IgG1-dependent pathway contributing to systemic allergic reactions.

Area of Science:

  • Immunology
  • Allergy Research
  • Mouse Models

Background:

  • Systemic anaphylaxis is a severe allergic reaction.
  • Immunoglobulin G1 (IgG1)-antigen immune complexes can trigger anaphylaxis.
  • The specific mechanisms underlying IgG1-dependent anaphylaxis require further elucidation.

Discussion:

  • Basophils play a key role in allergic responses.
  • Platelet-activating factor (PAF) is a potent mediator of inflammation.
  • The interaction between immune complexes, basophils, and PAF in anaphylaxis is complex.

Key Insights:

  • Tsujimura et al. demonstrate that basophil-derived platelet-activating factor (PAF) is essential for IgG1-antigen immune complex-mediated anaphylaxis in mice.
  • This study identifies a novel alternative pathway for systemic anaphylaxis driven by IgG1.

Related Experiment Videos

  • The findings highlight the significant contribution of PAF released by basophils in this specific anaphylactic pathway.

    • Outlook:

    • Further research into the precise signaling pathways involved in IgG1-dependent anaphylaxis.
    • Exploring potential therapeutic targets for IgG1-mediated allergic diseases.
    • Investigating the relevance of this pathway in human anaphylaxis.